Evidence map›Paper›PMID 31687171›Full record

ArticleObesity science & practice2019

Impact of anti-obesity medication initiation and duration on weight loss in a comprehensive weight loss programme.

R Safavi, A Lih, S Kirkpatrick, S Haller, M R Bailony

Open access · goldAbstract read
In one paragraph

Article in Obesity science & practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

R SafaviUniversity of California Santa Cruz California USA.
A LihResearch Department Enara Health Inc. San Mateo California USA.
S KirkpatrickResearch Department Enara Health Inc. San Mateo California USA.
S HallerResearch Department Enara Health Inc. San Mateo California USA.
M R BailonyResearch Department Enara Health Inc. San Mateo California USA.ORCID https://orcid.org/0000-0002-8673-021X
San Mateo County Health System · USUniversity of California, Santa Cruz · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis retrospective study aimed to evaluate the impact of anti-obesity medication (AOM) initiation, usage and duration on weight loss in a 72-week precision obesity programme. The type of AOM, diet and exercise plan was chosen based upon an individual's biological and psychosocial needs. The 72-week study duration allowed for a fair investigation of the downstream impact of delayed versus early AOM initiation.

methodsParticipants, aged ≥18 years with body mass index ≥30 kg m

resultsMean age and body mass index (

conclusionEarly initiation of AOM may enhance weight loss.

Indexed as

obesity treatmentweight lossweight management programmeweight‐reducing drugs

Identifiers

PMID31687171
PMCPMC6819971
OpenAlexW2956616780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.